- Home
- AREB vs IMRN Comparison
AREB vs IMRN Comparison
Compare AREB & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREB
- IMRN
- Stock Information
- Founded
- AREB 2014
- IMRN 1994
- Country
- AREB United States
- IMRN Australia
- Employees
- AREB N/A
- IMRN N/A
- Industry
- AREB Plastic Products
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- AREB Industrials
- IMRN Health Care
- Exchange
- AREB Nasdaq
- IMRN Nasdaq
- Market Cap
- AREB 10.4M
- IMRN 9.2M
- IPO Year
- AREB N/A
- IMRN N/A
- Fundamental
- Price
- AREB $1.42
- IMRN $1.88
- Analyst Decision
- AREB
- IMRN Strong Buy
- Analyst Count
- AREB 0
- IMRN 1
- Target Price
- AREB N/A
- IMRN $5.00
- AVG Volume (30 Days)
- AREB 1.2M
- IMRN 25.2K
- Earning Date
- AREB 08-13-2025
- IMRN 07-07-2025
- Dividend Yield
- AREB N/A
- IMRN N/A
- EPS Growth
- AREB N/A
- IMRN N/A
- EPS
- AREB N/A
- IMRN N/A
- Revenue
- AREB $9,887,755.00
- IMRN $4,048,286.00
- Revenue This Year
- AREB N/A
- IMRN N/A
- Revenue Next Year
- AREB N/A
- IMRN N/A
- P/E Ratio
- AREB N/A
- IMRN N/A
- Revenue Growth
- AREB N/A
- IMRN 82.90
- 52 Week Low
- AREB $1.10
- IMRN $1.50
- 52 Week High
- AREB $231.75
- IMRN $2.87
- Technical
- Relative Strength Index (RSI)
- AREB 36.40
- IMRN 58.70
- Support Level
- AREB $1.35
- IMRN $1.68
- Resistance Level
- AREB $1.48
- IMRN $1.94
- Average True Range (ATR)
- AREB 0.14
- IMRN 0.09
- MACD
- AREB 0.07
- IMRN 0.02
- Stochastic Oscillator
- AREB 8.64
- IMRN 76.92
About AREB American Rebel Holdings Inc.
American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.